Free Trial
OTCMKTS:OCPNY

Olympus (OCPNY) Stock Price, News & Analysis

Olympus logo
$18.00 -0.25 (-1.37%)
As of 01/31/2023

About Olympus Stock (OTCMKTS:OCPNY)

Key Stats

Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$16.80
$74.99
Volume
400 shs
Average Volume
860,265 shs
Market Capitalization
$23.15 billion
P/E Ratio
21.95
Dividend Yield
0.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Olympus Corporation, established in 1919 as Takachiho Seisakusho in Tokyo, is a leading global manufacturer specializing in medical and surgical equipment, scientific solutions and imaging products. Over its century-long history, the company has evolved from producing precision microscopes to pioneering minimally invasive endoscopy systems, positioning itself at the forefront of healthcare technology innovation.

At the core of Olympus’s operations is its Medical Systems division, which develops, manufactures and markets a suite of products for diagnostics and therapeutic endoscopy. Its portfolio includes video endoscopes, surgical energy devices, reprocessing equipment and advanced imaging platforms designed to enhance visualization and support minimally invasive procedures across gastrointestinal, urological and respiratory applications.

Beyond the medical field, Olympus serves scientific and industrial markets through its Scientific Solutions segment, offering high-resolution microscopes, life science research instruments and non-destructive testing equipment for material analysis. Although the company has historically been recognized for its photography and audio divisions, recent strategic realignments have shifted its primary focus toward healthcare and scientific research, while its legacy imaging heritage continues under specialized business units.

Operating in more than 40 countries, Olympus maintains a broad geographic presence with regional headquarters and R&D centers in Japan, Europe and North America. The company’s leadership team, currently headed by President and CEO Yasuo Takeuchi, is dedicated to driving growth through technological innovation, strategic partnerships and a commitment to improving patient outcomes and advancing scientific discovery on a global scale.

AI Generated. May Contain Errors.

Receive OCPNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

OCPNY Stock News Headlines

How high will gold surge?
Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold … and reveals a little-known way to get ahead of this bull market.
Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript
Olympus Teams Up With Sony for Surgical Big Screen TV
See More Headlines

OCPNY Stock Analysis - Frequently Asked Questions

Olympus' stock was trading at $18.00 at the start of the year. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00.
View the best growth stocks for 2025 here
.

Olympus Co. (OTCMKTS:OCPNY) released its quarterly earnings data on Thursday, August, 5th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of $0.10 by $0.03. The firm had revenue of $1.75 billion for the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a net margin of 13.80% and a trailing twelve-month return on equity of 24.30%.

The following companies are subsidiaries of Olympus: FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and others.

Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2021
Today
6/30/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Structural clay products
Sub-Industry
N/A
Current Symbol
OTCMKTS:OCPNY
CIK
N/A
Employees
31,557
Year Founded
1919

Profitability

Trailing P/E Ratio
21.95
Forward P/E Ratio
10.91
P/E Growth
1.07
Net Income
$1.03 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.74 billion
Cash Flow
$1.22 per share
Price / Cash Flow
14.76
Book Value
$3.50 per share
Price / Book
5.14

Miscellaneous

Outstanding Shares
1,285,890,000
Free Float
N/A
Market Cap
$23.15 billion
Optionable
Not Optionable
Beta
0.70

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:OCPNY) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners